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ABSTRACT
RIG-I recognizes molecular patterns in viral RNA
to regulate the induction of type I interferons. The
C-terminal domain (CTD) of RIG-I exhibits high
affinity for 50 triphosphate (ppp) dsRNA as well
as blunt-ended dsRNA. Structures of RIG-I CTD
bound to 50-ppp dsRNA showed that RIG-I recog-
nizes the termini of dsRNA and interacts with the
ppp through electrostatic interactions. However,
the structural basis for the recognition of
non-phosphorylated dsRNA by RIG-I is not fully
understood. Here, we show that RIG-I CTD binds
blunt-ended dsRNA in a different orientation
compared to 50 ppp dsRNA and interacts with both
strands of the dsRNA. Overlapping sets of residues
are involved in the recognition of blunt-ended dsRNA
and 50 ppp dsRNA. Mutations at the RNA-binding
surface affect RNA binding and signaling by RIG-I.
These results provide the mechanistic basis for
how RIG-I recognizes different RNA ligands.
INTRODUCTION
The RIG-I like receptors (RLRs) are cytosolic pattern
recognition receptors of viral RNA that mediate the
innate anti-viral immune responses (1–5). The RLR
family has three proteins, RIG-I, MDA5 and LGP2
(1,3,6). This family of proteins contains a DExD/H-Box
RNA helicase domain and a C-terminal RNA-binding
domain. Both RIG-I and MDA5 also contain two
caspase activation and recruitment domains (CARDs) at
their N-termini (7). In contrast, LGP2 lacks the CARDs
and associated signaling capability. It regulates RIG-I and
MDA5 signaling (8–11). RIG-I and MDA5 sense
overlapping sets of viruses (12–14). The essential roles of
RIG-I and MDA5 in antiviral immunity were conﬁrmed
in gene knock-out mice (12,15).
Since RNA can fold into complicated three-dimensional
structures and contain various modiﬁcations, especially at
their termini, it is not clear what is the exact structural
feature of the viral RNA recognized by the RLRs and how
RNA binding activates RLR signaling. RNA transcripts
containing a 50 triphosphate (ppp) potently trigger the
activation of RIG-I upon transfection into cells (16,17).
Recent studies using chemically synthesized dsRNA or
hairpin RNA containing 50 ppp further demonstrated
that base pairing near the 50 ppp is necessary for RIG-I
activation (18–20). In addition, the genomic RNA of
inﬂuenza A and Sendai viruses were identiﬁed as physio-
logical agonist of RIG-I (20,21). It was suggested that the
panhandle structure of the inﬂuenza A virus genomic
RNA is likely recognized by RIG-I (20,22). Moreover,
blunt-ended dsRNA without 50 ppp can also activate
RIG-I signaling in transfected cells (11,23). To make
ligand recognition even more complex, the digestion of
the dsRNA mimetic poly (I:C) by RNase III to fragments
of <1kb transforms poly (I:C) from an activator of
MDA5 to an activator of RIG-I (24). Consistent with
this, short RNA generated by RNase L digestion of
cellular RNA induced interferon (IFN) production via
RIG-I and MDA5 (25). These results indicated that the
50 ppp is not absolutely needed for the activation of RIG-I
by RNA. Clearly, how RIG-I recognizes such a wide
range of ligands need to be better deﬁned.
The CTD of RIG-I is the RNA-binding domain and
in vitro binding studies using puriﬁed RLR CTDs and
RNAs with deﬁned structures have been widely used to
elucidate the structural features of RNAs recognized by
the RLRs (11,26–30). The RIG-I CTD binds 50 ppp
dsRNA, blunt-ended dsRNA and 50 ppp ssRNA, with
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crystal structure of LGP2 CTD bound to an 8-bp
blunt-ended dsRNA provided the ﬁrst evidence that the
termini of dsRNA are recognized by the RLRs (11). The
crystal structures of RIG-I CTD bound to a 14-bp
GC-rich and a 12-bp AU-rich 50 ppp dsRNA conﬁrmed
that RIG-I CTD also recognizes the termini of 50 ppp
dsRNA (30). A similar mode of RNA binding was
observed in the structure of RIG-I CTD bound to a dif-
ferent 12-bp dsRNA (31). These structures showed that
the 50 ppp of the dsRNA is recognized by a cluster of
positively charged residues including Lys858, Lys861,
Lys888 and His847 (30,31). In contrast, both MDA5
and LGP2 CTDs bind blunt-ended dsRNA with no pref-
erence for 50 ppp dsRNA (11,27). Consistent with this,
structures of MDA5 and LGP2 CTDs showed that these
two proteins lack the ppp-binding site observed in RIG-I
CTD. Comparisons of the structures of RIG-I CTD
bound to 50 ppp dsRNA and LGP2 CTD bound to
blunt-ended dsRNA showed that the dsRNA were in
dramatically different orientations (30). These observa-
tions led us to hypothesize that RIG-I CTD will bind
blunt-ended dsRNA and 50 ppp dsRNA in different
ways (30).
To understand the promiscuous RNA binding by
RIG-I, we determined the crystal structure of RIG-I
CTD bound to a 14-bp blunt-ended dsRNA at 2.4-A ˚ reso-
lution and compared the structure of RIG-I CTD bound
to 50 ppp dsRNA of the same sequence. These two struc-
tures revealed that distinct but overlapping sets of residues
are involved in the binding of blunt-ended dsRNA and
50 ppp dsRNA. The orientation of blunt-ended dsRNA
relative to RIG-I CTD is dramatically different from
that of the 50 ppp dsRNA. Mutagenesis of key residues
at the RNA-binding surface affected RNA binding in vitro
and RIG-I signaling in vivo.
MATERIALS AND METHODS
Puriﬁcation, crystallization and structural determination
Human RIG-I CTD was expressed and puriﬁed as
described (32). The 14-bp blunt-ended dsRNA was chem-
ically synthesized by IDT (Coralville, IA, USA). The
dsRNA was mixed with excess RIG-I CTD and the 2:1
(RIG-I CTD:dsRNA) complexes were puriﬁed by gel
ﬁltration chromatography on a Superdex75 (1.6 60)
column (GE Healthcare). The complex was concentrated
to  20mg/ml and crystallized in 27% polyethylene glycol
500 monomethyl ether (PEG MME 500) in 0.1M HEPES
buffer at pH 7.5. The crystals were ﬂash frozen in liquid
nitrogen. Diffraction data were collected using a Rigaku
RAXIS IV
+ +detector and processed with HKL2000 (32).
The complex crystallizes in space group P212121 with cell
dimensions: a=36.99A ˚ , b=70.30A ˚ , c=125.54A ˚ . The
crystallographic asymmetric unit (ASU) contains one
2:1 (RIG-I CTD:dsRNA) complex. Structures of RIG-I
CTD in the complex was determined by molecular
replacement with MOLREP (33) using the structure of
RIG-I CTD bound to a 14-bp 50 ppp dsRNA as search
model (PDB code: 3LRN). The structural model was
rebuilt using O (34). After several rounds of reﬁnement
with CNS (35), electron density for the dsRNA became
obvious. A 14-bp dsRNA was manually docked into the
electron density map and rebuilt with O. The structure was
reﬁned using CNS. Statistics of data collection and struc-
tural reﬁnement are shown in Table 1. The structural
ﬁgures were generated with PyMol (http:///www.pymol
.org).
RNA-binding studies
Different forms of RNA were generated either by
chemical synthesis or by in vitro transcription using T7
RNA polymerase. The in vitro transcribed RNA were
puriﬁed by gel ﬁltration chromatography and analyzed
by denaturing polyacrylamide gel electrophoresis.
Sequences of all the RNA and DNA oligos used in this
study are shown in Supplementary Table S1. Double-
stranded RNA was generated by heating the ssRNA at
95 C for 5min and cooling gradually to room tempera-
ture. In the binding studies by gel ﬁltration chromatog-
raphy, the RNA samples (at  100mM) were mixed with
equal volume of RIG-I CTD (at  200mM) and 100mlo f
samples were injected over a Superdex200 (10/300 GL)
column (GE Healthcare) eluted with a buffer containing
20mM Tris and 150mM NaCl at pH 7.5.
In the binding studies by electrophoretic mobility shift
assays (EMSAs), each type of RNA was mixed with
RIG-I CTD at a molar ratio 1:3 at a ﬁnal concentration
of  1.6:5mM. The mixtures were resolved on 12% poly-
acrylamide gel and stained with ethidium bromide.
Mutants of RIG-I CTD were generated using the
Quikchange mutagenesis kit (Stratagene). The mutant
proteins were expressed and puriﬁed the same way as
the wild-type protein. RNA-binding studies for the
mutants were conducted by EMSA and gel ﬁltration
chromatography.
IFN-b luciferase reporter gene assays
IFN-b luciferase reporter gene assays were used to analyze
the activities of three different forms of RNA in
stimulating RIG-I signaling in HEK 293T cells according
to protocols described previously (30). Brieﬂy, the cells
were transfected with plasmid of RIG-I along with
IFN-b luciferase reporter plasmid and Renilla luciferase
control plasmid. After 24h, three different forms of RNA
(Supplementary Table S1) at 5, 10 and 50nM concentra-
tions were transfected into the cells to stimulate RIG-I
dependent signaling. The ratios of ﬁreﬂy luciferase
reporter over Renilla luciferase control were determined.
Signaling of RIG-I mutants were analyzed under similar
conditions in cells stimulated with these three forms of
RNA at a ﬁnal concentration of 50nM.
RESULTS
RIG-I CTD binds blunt-ended dsRNA
We synthesized a 14-bp blunt-ended dsRNA, two 14-bp
dsRNA with either 50 or 30 overhangs, a 14-bp dsDNA
and a 13-bp RNA:DNA hybrid (Supplementary Table S1)
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Gel ﬁltration chromatography showed that RIG-I CTD
binds blunt-ended dsRNA and forms a stable complex
(Figure 1A). Based on the gel ﬁltration chromatograms
of the RIG-I CTD:dsRNA mixtures at different molar
ratios (Figure 1A), the stoichiometry between RIG-I
CTD and the 14-bp blunt-ended dsRNA is estimated
to be 2:1. Binding studies by EMSA also showed that
RIG-I CTD binds blunt-ended dsRNA as well as 50 ppp
dsRNA (Figure 1F). However, the non-phosphorylated
14-bp dsRNA with 50 overhangs failed to bind RIG-I
CTD (Figure 1B and F). Although the dsRNA with 30
overhangs still binds RIG-I CTD by EMSA (Figure 1F),
gel ﬁltration chromatography showed it binds RIG-I CTD
with reduced afﬁnity and does not form the stoichiometric
2:1 complex (Figure 1C). In addition, gel ﬁltration
chromatography showed that RIG-I CTD does not
bind a 14-bp dsDNA with the same sequence as the
14-bp blunt-ended dsRNA (Figure 1D). Furthermore,
a 13-bp blunt-ended RNA:DNA hybrid also binds
RIG-I CTD (Figure 1E). The stoichiometry between
RIG-I CTD and the RNA:DNA hybrid is estimated
to be 1:1.
Overall structure of RIG-I CTD bound to
blunt-ended dsRNA
To elucidate the structural basis of blunt-ended dsRNA
recognition by RIG-I, we determined the crystal structure
of RIG-I CTD bound to a 14-bp blunt-ended dsRNA
(Figure 2A and Supplementary Figure S1). The structure
showed that one RIG-I CTD bound to each terminus of
the blunt-ended dsRNA, forming a complex with pseudo
2-fold symmetry (Figure 2A). Structures of the two RIG-I
CTDs in the complex are essentially the same (r.m.s.d.
0.6A ˚ ) and the two RIG-I CTDs bind the dsRNA in
similar ways. Discussions of the structure will be based
on the interface between RIG-I CTD chain A and the
dsRNA due to better-deﬁned electron density throughout
this interface.
The overall structure of the RIG-I CTD:dsRNA
complex looks like two hands holding a stack of chips
(Figure 2A). The exposed base pairs at the termini of
the dsRNA stack on the loop connecting strands b5
and b6 (loop 5–6), interacting with RIG-I CTD
through hydrophobic interactions (Figure 3A). The
thumb, corresponding to the loop connecting strand
b10 and the C-terminal helix, reaches into the major
groove of the dsRNA and interacts with the RNA
through electrostatic interactions (Figure 2A). The struc-
ture of RIG-I CTD shows shape and charge comple-
mentarity with the ﬁrst-turn of the blunt-ended
dsRNA (Figure 2B). The average shape correlation
statistics (Sc) shows the two interfaces have an average
Sc of 0.67, a better match compared to the interface
between RIG-I CTD and 50 ppp dsRNA (Sc=0.62);
an Sc value of 1.0 indicates a perfect ﬁt between two
interacting surfaces (36).
The 50 4nt of the dsRNA make major contributions to
RNA binding, contributing to  770A ˚ 2 of buried surface
area (Figure 3A). However, unlike similar dsRNA with
50 ppp, the complementary strand also makes signiﬁcant
contribution to binding (buried surface area of  540A ˚ 2,
Figure 3B and C). The total buried surface area at the
blunt-ended dsRNA:RIG-I CTD interface ( 1310A ˚ 2)i s
slightly larger than that at the 50 ppp dsRNA: RIG-I CTD
interface ( 1200A ˚ 2).
Interactions between RIG-I CTD and the blunt-ended
dsRNA
The interaction between the blunt-ended dsRNA and
RIG-I CTD contains a mixture of electrostatic, direct
and solvent mediated hydrogen bonding, hydrophobic
and van der Waals interactions (Supplementary
Table S2). The ﬁrst 4nt at the 50 end of the dsRNA
interact with RIG-I CTD in a similar manner as dsRNA
containing 50 ppp (Figure 3A) (30). The 20-hydroxyl of nu-
cleotide G1 forms a hydrogen bond with the side chain of
His830 (Figure 3A). This is the only direct contact between
the ribose and the protein. This hydroxyl group also forms
two solvent-mediated hydrogen bonds with backbone
amine and carbonyl groups of Tyr831 and Ile887. This
ribose also has van der Waals contacts with two hydro-
phobic residues Val886 and Ile875. The second nucleotide
(G2) interacts with RIG-I CTD through three
solvent-mediated hydrogen bonds with residues Ser906,
Trp908 and Glu890. G2 also has van der Waals contacts
with Lys888 and His830. The third nucleotide C3 interacts
with RIG-I CTD mainly through solvent mediated
hydrogen bonds between its phosphodiester and the
backbone amines of Trp908 and Lys909. The side chain
amine of Lys907 interacts with the phosphodiester of G4
through electrostatic interactions (Figure 3A and C).
Although similar interactions were also observed in the
complex between 50 ppp dsRNA and RIG-I CTD, the
Table 1. Statistics of crystallographic analysis
Diffraction data
Space group P212121
Unit cell a=36.99A ˚ , b=70.30A ˚ , c=125.54A ˚
Asymmetric unit one 2:1 RIG-I CTD:dsRNA complex
Resolution (A ˚ ) 50.0–2.40 (2.49–2.40)
a
Unique reﬂections 13384
Redundancy 6.0 (5.8)
Completeness 99.1% (98.0%)
<I/sI> 29.5 (5.3)
Rsym(%) 8.6 (44.8)
Reﬁnement
Resolution (A ˚ ) 50–2.4A ˚
Reﬂections (F>0)
(total/test set)
12860/1329
Protein atoms 2098
RNA atoms 596
Zinc ions 2
Solvent atoms 133
Rcryst/Rfree (%) 21.7/27.9
R.m.s.d. bond length 0.006A ˚
R.m.s.d. bond angle 1.32 
aValues in the parentheses are for the highest resolution shell; 10% of
reﬂections are used in the test set for Rfree calculation.
Nucleic Acids Research,2011, Vol.39, No. 4 1567Figure 1. RIG-I CTD binds blunt-ended dsRNA without 50 ppp. (A) Binding studies of RIG-I CTD with the 14-bp blunt-ended dsRNA by gel
ﬁltration chromatography. RIG-I CTD, the 14-bp blunt-ended dsRNA and mixtures of RIG-I CTD:dsRNA at molar ratios 1:1 to 4:1 were injected
over a superdex200 column. Elution proﬁle of RIG-I CTD is in black and the dsRNA in red. Elution proﬁles of mixtures of RIG-I CTD and the
14-bp dsRNA at molar ratios 1:1, 2:1, 3:1 and 4:1 are in green, blue, cyan and purple, respectively. The molecular masses of four protein standards
and their elution positions are shown above the chromatograms. (B) Binding studies of RIG-I CTD with a 14-bp dsRNA containing 50 AUAU
overhangs. A 2:1 mixture of RIG-I CTD and the dsRNA was analyzed by gel ﬁltration chromatography. (C) Binding studies of RIG-I CTD with a
14-bp dsRNA containing 30AUAU overhangs. The molar ratio between RIG-I CTD and the dsRNA is 2:1 in the sample. (D) Binding studies of
RIG-I CTD with a 14-bp blunt-ended dsDNA with the same sequence as the 14-bp blunt-ended dsRNA. The molar ratio between RIG-I CTD and
the dsDNA is 2:1. (E) Binding studies of RIG-I CTD with a 13-bp RNA:DNA hybrid. The molar ratio between RIG-I CTD and the RNA:DNA
hybrid is 2:1. (F) Binding studies of RIG-I CTD with the 14-bp 50 ppp dsRNA, 14-bp blunt-ended dsRNA and 14-bp dsRNA with either 50 or 30
overhangs by EMSA.
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RIG-I CTD (Figure 3C).
Several nucleotides from the complementary strand also
make signiﬁcant contributions to blunt-ended dsRNA
binding (Figure 3B and C). Key contributions likely
come from positively charged Arg811 and His871 that
interact with the phosphodiester of C7 and G8 through
electrostatic interactions (Figure 3B and C). Notably,
these interactions are not observed in the structures of 50
ppp dsRNA bound to RIG-I CTD (Figure 3C). The side
chain of Lys849 is within 4A ˚ of the phosphodiester of
C11 and G12, and might interact with the RNA through
additional electrostatic interactions (Figure 3B and C).
Moreover, the side chain amine of Lys851 is 3.7A ˚ away
from the phosphate of C14 and interacts with the RNA
through electrostatic interactions (Figure 3B and C).
Apart from these electrostatic interactions, three solvent-
mediated hydrogen bonds are observed between nucleo-
tides C5 and G6 and residues Leu904, Arg811 and Ser906.
The exposed GC base pair at the termini of the dsRNA
interacts with RIG-I CTD primarily through hydrophobic
interactions by stacking its guanine ring on the phenyl
side chain of Phe853 (Figure 3A). The guanine base also
forms a hydrogen bond with the side chain of Lys858
(Figure 3A). A purine base at the 50-terminus of the
dsRNA should stack more effectively on the phenyl ring
of Phe853 than a pyrimidine base.
The structure of RIG-I CTD bound to the blunt-ended
dsRNA indicates that residues Arg811, Lys812 and His871
mayplaycriticalrolesinthespeciﬁcbindingofblunt-ended
dsRNA. To test this prediction, we puriﬁed RIG-I CTD
mutants R811E, R811S, K812E, K812S, H871E and con-
ducted RNA-binding studies (Figure 4 and Supplementary
Figure S2). Substitution of Arg811 with glutamate almost
abolished blunt-ended dsRNA binding and signiﬁcantly
reduced binding to both 50-ppp dsRNA and ssRNA
(Figure 4). Replacement of Arg811 by a hydrophilic
serine reduced the binding of blunt-ended dsRNA, but
did not affect binding to triphosphorylated dsRNA or
ssRNA (Figure 4). Substitution of the nearby Lys812 by
glutamate dramatically reduced blunt-ended dsRNA
binding, but only slightly reduced binding to triphos-
phorylated dsRNA or ssRNA (Figure 4). Replacement of
Lys812 by a neutral serine residue did not affect RNA
binding (Supplementary Figure S3). Surprisingly, the re-
placement of His871 by glutamate did not affect the
binding to all three forms of RNA (Figure 4), suggesting
that the His871 makes only minimal contribution to RNA
binding. As expected, the replacement of Arg866, a residue
not at the RNA-binding surface, by glutamate did not
affect RNA binding (Figure 4). The slightly slower migra-
tion of the R866E and H871E complex is likely due to the
changes of the surface electrostatics of the mutant proteins.
In addition, our previous studies showed that mutation
K907E disrupted blunt-ended dsRNA as well as 50-ppp
dsRNA binding (30). Together, these results suggest that
the electrostatic interactions between Arg811 and Lys907
and the dsRNA are essential for blunt-ended dsRNA
binding. Furthermore, previous studies showed that substi-
tution of Phe853 by serine also reduced dsRNA binding
(30), suggesting the hydrophobic interaction between
Phe853 and the exposed base pair is also needed for effect-
ive RNA binding.
Blunt-ended dsRNA and 50-ppp dsRNA bind RIG-I CTD
in different orientations
The structure presented above and the structures of 50 ppp
dsRNA bound to RIG-I CTD (30) revealed that RIG-I
CTD binds triphosphorylated and non-phosphorylated
Figure 2. Crystal structure of human RIG-I CTD bound to a 14-bp
blunt-ended dsRNA. (A) Structure of RIG-I CTD bound to the
dsRNA. RIG-I CTDs are shown by the green ribbons. The dsRNA
is shown by the sticks representation. Carbon atoms of the two RNA
strands are colored cyan and pink, respectively. The zinc ion bound to
RIG-I CTD is shown by the gray sphere. The complex exhibits pseudo
2-fold non-crystallographic symmetry. The pseudo 2-fold axis is shown
by the black oval. (B) Surface electrostatics of RIG-I CTD. Positively
charged surface is colored blue and negatively charged surface red. The
blunt-ended dsRNA bound to RIG-I CTD is shown by the stick
models. Key residues mediating blunt-ended dsRNA recognition are
labeled. Location of the ppp-binding site for 50 ppp dsRNA is indicated
by the white asterisk.
Nucleic Acids Research,2011, Vol.39, No. 4 1569Figure 3. Structural basis of blunt-ended dsRNA recognition by RIG-I CTD. (A) Interactions between the 50 4nt of the 14-bp blunt-ended dsRNA
and RIG-I CTD. The dsRNA is shown by the stick models. Carbon atoms of the RNA strand interacting with RIG-I CTD are colored cyan. The
complementary strand is colored light gray. RIG-I CTD is shown by the green ribbons. Key residues involved in RNA binding are shown by the
magenta stick models. (B) Interactions between complementary strand and RIG-I CTD. The complementary strand is shown by the stick models
with carbon atoms colored pink. (C) Schematic representations of the interactions between RIG-I CTD and the 14-bp blunt-ended dsRNA (left) and
a 14-bp 50 ppp dsRNA (right). Nucleotides in the two dsRNA are labeled the same way for comparison. Interactions between the dsRNA and one of
the two RIG-I CTD molecules are shown.
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blunt-ended dsRNA needs to swing towards RIG-I CTD
by  15  relative to 50-ppp dsRNA to increase its contacts
with the protein (Figure 5A). Surprisingly, the interactions
between the 50 4nt of the blunt-ended dsRNA and RIG-I
CTD are similar to those observed in the structures of
50-ppp dsRNA bound to RIG-I CTD (30). No rotation
along the helical axis of the dsRNA is necessary for RIG-I
CTD to interact with these two different forms of dsRNA.
It is obvious that the speciﬁc interactions between the ppp
and RIG-I CTD determine how 50-ppp dsRNA binds
RIG-I CTD, while the interactions between the phospho-
diester backbones of the dsRNA and the protein deter-
mine how the blunt-ended dsRNA binds RIG-I CTD.
Superposition of RIG-I CTDs in the two complexes
showed that the structures of RIG-I CTDs are almost
the same (r.m.s.d. 0.5A ˚ , Figure 5A), indicating only
minor conformational adjustment of RIG-I CTD is
needed to bind these two forms of RNA. These structures
show that RIG-I CTD is a versatile RNA-binding module
that uses similar binding surfaces to recognize different
forms of RNA.
Comparison of the structures of RIG-I and LGP2
CTDs bound to blunt-ended dsRNA showed that the
dsRNA bind the two CTDs in signiﬁcantly different orien-
tations as well (Figure 5B). The interaction between LGP2
CTD and the dsRNA is more extensive (buried surface
area of  1540A ˚ 2) and shows slightly higher shape
complementarity (Sc=0.70) (11). To bind the LGP2
CTD, the dsRNA needs to rotate along its helical axis
and swing towards the protein by  15  relative to the
position of the blunt-ended dsRNA bound to RIG-I
CTD (Figure 5B). Even though the overall structures of
RIG-I and LGP2 CTDs bound to dsRNA are similar
(r.m.s.d. 1.35A ˚ ), the conformations of loop5–6 that
contact the exposed base pairs are quite different
(Figure 5B and C). The surface electrostatics of RIG-I
and LGP2 CTDs are also dramatically different
(Figure 5D). Critical residues Arg811 and His871
involved in blunt-ended dsRNA binding by RIG-I CTD
are replaced by hydrophobic Ile557 and negatively
charged Glu617 in LGP2 CTD (Figure 5D). These struc-
tural differences resulted in the dramatically different
mode of blunt-ended dsRNA binding by RIG-I and
LGP2 CTDs.
The overall structures of RIG-I, LGP2 and MDA5
CTDs are highly conserved (r.m.s.d. 1.5A ˚ , Figure 5C).
The largest structural differences occur at the N-terminal
or C-terminal regions, which are quite ﬂexible (Figure 5C).
The loops (loop5–6) connecting strands b5 and b6 also
show high degree of ﬂexibility (Figure 5C). The conform-
ation of this loop may determine how the RLRs recognize
the exposed base pair at the termini of the dsRNA and
likely inﬂuence the orientation of the RNA bound to the
RLRs. RNA-binding studies by NMR spectroscopy
showed that MDA5 CTD uses a similar binding surface
as RIG-I and LGP2 to bind blunt-ended dsRNA (27).
Mutations at the RNA-binding surface affect
RIG-I signaling
The activities of three different forms of RNA in
stimulating RIG-I signaling were examined by IFN-b
luciferase reporter gene assays. These studies show that
both blunt-ended dsRNA and 50 ppp dsRNA were
capable of activating RIG-I-dependent reporter activities
(Figure 6A). However, when the RNAs were used at 5nM
concentrations, 50 ppp dsRNA shows higher activity than
blunt-ended dsRNA or 50 ppp ssRNA (Figure 6A).
Together with the results from our previous studies (30),
we demonstrated that blunt-ended dsRNA can stimulate
RIG-I signaling in cells.
To test how mutations of key residues at the RNA-
binding surface affect RIG-I signaling, we generated ﬁve
mutants in the context of full-length RIG-I and conducted
IFN-b luciferase assays. Expressions of wild-type and
mutants of RIG-I in the transfected cells were conﬁrmed
by western blot (Figure 6B, inset). Substitution of Arg811
with glutamate abolished RIG-I signaling for both
blunt-ended dsRNA and 50 ppp dsRNA (Figure 6B).
Although the replacement of Lys812 by glutamate does
not disrupt 50 ppp dsRNA binding by RIG-I CTD, this
mutation abolished signaling for both blunt-ended
dsRNA and 50 ppp dsRNA (Figure 6B). However, substi-
tution of His871 with glutamate only reduced RIG-I sig-
naling to 50 ppp dsRNA by  30%, but reduced signaling
by blunt-ended dsRNA by  50% (Figure 6B). Consistent
with results from RNA-binding studies by RIG-I CTD
Figure 4. Mutations at the blunt-ended dsRNA-binding surface affect
RNA binding by RIG-I CTD. (A) Binding studies of wild-type
and mutants of RIG-I CTD with the 14-bp blunt-ended dsRNA
by EMSA. (B) Binding studies of RIG-I CTD mutants with a 14-bp
50 ppp dsRNA. (C) Binding studies of RIG-I CTD mutants with a
13-nt 50 ppp ssRNA.
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with serine only slightly reduced RIG-I signaling by
50 ppp dsRNA, but reduced the signaling by blunt-ended
dsRNA by  60% (Figure 6B). In contrast, a serine sub-
stitution of the nearby Lys812 reduced signaling by
blunt-ended dsRNA and 50 ppp dsRNA by  80%
(Figure 6B). These results demonstrated that the two posi-
tively charged residues, Arg811 and Lys812, play critical
roles in the recognition of blunt-ended dsRNA by RIG-I.
In addition, previous studies demonstrated that substitu-
tions of any of the three positively charged residues,
Lys888, Lys907 or Lys909, by glutamate also abolished
RIG-I activation by both blunt-ended dsRNA and
50 ppp dsRNA (30). Moreover, hydrophobic interactions
between the exposed base pair and RIG-I CTD are also
important for the function of RIG-I; substitution of
Phe853 by serine severely decreased RIG-I signaling in
response to all the three forms of RNA (30).
DISCUSSION
To elucidate the structural features of viral RNA
recognized by RIG-I, we expressed human RIG-I CTD,
conducted RNA-binding studies, and in this and previous
studies, determined the structures of RIG-I CTD bound to
two different forms of RNA. These studies demonstrated
that RIG-I CTD binds triphosphorylated dsRNA or
ssRNA as well as blunt-ended dsRNA (30). The crystal
structures of RIG-I CTD bound to a 14-bp blunt-ended
dsRNA and 50 ppp dsRNA revealed that distinct but
overlapping sets of residues contact the RNA (30).
Mutations of key residues at the RNA-binding surface
differentially affect RNA binding and signaling by
RIG-I. These results demonstrated that RIG-I CTD is a
versatile RNA-binding module capable of recognizing
various RNA structures. The crystal structures of
RIG-I, LGP2 and MDA5 CTDs in isolation (27–29) and
the structures of RIG-I and LGP2 CTDs bound to RNA
Figure 5. RIG-I and LGP2 CTDs bind blunt-ended dsRNA and 50 ppp dsRNA differently. (A) Superposition of RIG-I CTD bound to the 14-bp
blunt-ended dsRNA and a 14-bp 50 ppp dsRNA with the same sequence. RIG-I CTDs bound to the blunt-ended dsRNA (blue) and the 50 ppp
dsRNA (red) are shown by the green and cyan ribbons, respectively. (B) Superposition of RIG-CTD bound to the blunt-ended dsRNA and the
50 ppp dsRNA and LGP2 CTD bound to blunt-ended dsRNA. The blunt-ended dsRNA bound to RIG-I CTD is shown by the blue ribbons. The
50 ppp dsRNA bound to RIG-I CTD is shown by the orange ribbons. A 14-bp dsRNA (magenta ribbons) is superimposed on the 8-bp dsRNA in the
LGP2 CTD:dsRNA complex structure to facilitate comparisons. (C) Superposition of RIG-I (ligand bound), MDA5 (ligand free) and LGP2 (ligand
bound) CTD structures. The RNA-binding surfaces of the proteins face the reader. (D) Electrostatics of the RNA-binding surfaces of the RLR
CTDs. Positively charged surfaces are colored blue and negatively charged surfaces are red. The ppp-binding site of RIG-I CTD and corresponding
regions of LGP2 and MDA5 are indicated by the green circles. Key residues involved in RNA-binding are labeled. Residues of RIG-I CTD
interacting with the complementary strand of the dsRNA and corresponding residues in MDA5 and LGP2 CTDs are underlined.
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properties of the RLRs.
A key question about the functions of the RLRs is what
structural features of RNAs are recognized by these
proteins. Biochemical, biophysical and cell-based
approaches have been employed to elucidate the structures
of RIG-I agonists. Several different techniques such as
surface plasmon resonance (SPR), gel ﬁltration chroma-
tography and EMSA have been used to study the RNA-
binding properties of RIG-I. These studies clearly showed
that RIG-I CTD binds 50 ppp ssRNA or dsRNA and
blunt-ended dsRNA, but does not associate with
dsDNA(11,30). Non-phosphorylated dsRNA with50 over-
hangs failed to bind RIG-I CTD, while dsRNA with
30 overhangs retained some binding. In contrast,
triphosphorylated dsRNA with either 30 or 50 overhangs
still bind RIG-I CTD (30). Although the RNA:DNA
hybrid still binds RIG-I CTD, it forms a 1:1 instead of a
1:2 complex with RIG-I CTD, suggesting that RIG-I
CTD only recognizes one terminus of the hybrid with
the RNA at the 50-end. It is likely that RIG-I CTD does
not bind the terminus of the hybrid with the DNA at the
50-end. The afﬁnity of 50 ppp dsRNA ( 0.3nM) for RIG-I
CTD is higher than that of 50 ppp ssRNA ( 5nM) or
blunt-ended dsRNA ( 8nM) (30). The afﬁnities of
RIG-I CTD for blunt-ended dsRNA and 50 ppp dsRNA
determined by isothermal titration calorimetry (ITC) are
signiﬁcantly lower than those determined by SPR (31).
This is likely due to the techniques used and the salt con-
centrations in the samples. These studies demonstrated
that blunt-ended dsRNA and triphosphorylated dsRNA
or ssRNA are all ligands for RIG-I. Consistent with these
results, all three forms of RNA activate RIG-I signaling in
cells (20,37).
The structures of RIG-I CTD bound to blunt-ended
dsRNA and 50 ppp dsRNA provided insight into how
RIG-I recognizes different forms of RNA. The two struc-
tures revealed that overlapping sets of residues are
involved in the recognition of these two forms of RNA
(30). The ﬁrst 4nt at the 50 end of triphosphorylated
dsRNA make major contributions to 50 ppp dsRNA
binding. The ppp interacts with a cluster of positively-
charged residues including Lys851, Lys858, Lys861,
His847 and Lys888 through multiple electrostatic
Figure 6. Mutations at the RNA-binding surface affect RIG-I signaling. (A) Effects of structures of the RNA ligands on the activation of IFN-b
luciferase production. The assay shows the activities of a 27-nt 50 ppp ssRNA (3PssR27), a 24-bp 50 ppp dsRNA (3PdsR24) and a 27-bp blunt-ended
dsRNA (dsR27) in stimulating RIG-I signaling in HEK 293T cells. The error bars correspond to the standard deviations of signals from three
independent transfections. (B) Effects of mutations at the RNA-binding surface on IFN-b luciferase production in cells transfected with a 27-bp
blunt-ended dsRNA and a 24-bp dsRNA with 50 ppp. Expression of the wild-type and mutants of RIG-I in the transfected cells were conﬁrmed by
western blot (inset).
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additional interactions with the protein through a combin-
ation of electrostatic, hydrogen bonding and van der
Waals interactions. Based on the structure of RIG-I
CTD bound to 50 ppp dsRNA, removal of the ppp
should dramatically reduce dsRNA binding (30).
However, RIG-I CTD can bind blunt-ended dsRNA
without ppp with nanomolar afﬁnity (30). This is likely
achieved through additional electrostatic interactions
between the complementary strand and Arg811 and
His871 in RIG-I CTD. Consistent with this observation,
replacement of Arg811 with glutamate had severe effects
on blunt-ended dsRNA binding, but had a more modest
effect on the binding of triphosphorylated dsRNA or
ssRNA binding. Moreover, substitution of R811 with
serine only reduced the signaling of blunt-ended dsRNA.
The 20-hydroxyl of the ribose makes limited contribu-
tions to dsRNA binding. Only the 20-hydroxyl of the
50-terminal nucleotide is involved in direct and solvent
mediated hydrogen bonds with RIG-I CTD.
Modiﬁcation of this hydroxyl by methylation reduced
the activity of 50 ppp dsRNA in stimulating RIG-I signal-
ing (31). It is likely the steric hindrance caused by this
modiﬁcation reduced RNA binding. However, it is not
clear why methylation of the 20-hydroxyl of the second
nucleotide also reduced RIG-I signaling (31), since this
ribose makes no direct contact with RIG-I CTD.
RIG-I CTD in complex with the blunt-ended dsRNA
crystallized in a different crystal form compared to the
complex with corresponding 50 ppp dsRNA. The
blunt-ended dsRNA complex did not crystallize under
the conditions of the 50 ppp dsRNA complex, and the
50 ppp dsRNA complex did not crystallize under the con-
ditions for the blunt-ended dsRNA complex. The crystal
packings for the two complexes are signiﬁcantly different.
This suggested the two forms of dsRNA bind RIG-I CTD
in different orientations in solution. Although the ppp can
be ﬂexible in solution, it has to adopt a speciﬁc conform-
ation to bind RIG-I effectively, so it is unlikely that 50 ppp
dsRNA will bind RIG-I CTD in a similar orientation as
the blunt-ended dsRNA. This orientation may reduce the
speciﬁc interactions between the ppp and RIG-I CTD.
Crystal structures of RIG-I and LGP2 CTDs bound to
dsRNA showed that the two proteins use similar binding
surfaces to interact with RNA (Figure 5B). Results from
NMR titration of MDA5 CTD with an 8-bp blunt-ended
dsRNA suggested that similar binding surface is involved
in RNA binding by MDA5 (27,38). Like RIG-I, both
MDA5 and LGP2 CTD bind to the termini of the
blunt-ended dsRNA (11,27). Some major differences in
RNA binding by the three RLRs should be emphasized,
however. Although LGP2 CTD binds dsRNA with
30 overhangs, it does not bind dsRNA with 50 overhangs
(11). MDA5 CTD only binds blunt-ended dsRNA but not
dsRNA with 50 or 30 overhangs (27). The RNA-binding
surfaces of the three proteins exhibit dramatically different
electrostatic potential (Figure 5D) that should contribute
to different modes of protein:RNA interactions. The
cluster of positively charged residues around Lys861 and
Lys858 involved in ppp recognition is only observed at the
RNA-binding surface of RIG-I (Figure 5D), explaining
why both LGP2 and MDA5 CTDs have no preference
for RNA ligands with 50 ppp (27,30). The differences in
surface electrostatics also explain why RIG-I and LGP2
CTDs bind dsRNA in different ways. The differences
should contribute to the function of these three innate
immune receptors in the detection of viral infections.
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